vs
Side-by-side financial comparison of STURM RUGER & CO INC (RGR) and Vericel Corp (VCEL). Click either name above to swap in a different company.
STURM RUGER & CO INC is the larger business by last-quarter revenue ($151.1M vs $92.9M, roughly 1.6× Vericel Corp). On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs 3.6%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $12.3M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 5.1%).
Sturm, Ruger & Company, Inc., better known by the shortened name Ruger, is an American firearm manufacturing company based in Southport, Connecticut, with production facilities also in Newport, New Hampshire; Mayodan, North Carolina; and Prescott, Arizona. The company was founded in 1949 by Alexander McCormick Sturm and William B. Ruger and has been publicly traded since 1969.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
RGR vs VCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $151.1M | $92.9M |
| Net Profit | — | $23.2M |
| Gross Margin | 17.8% | 78.7% |
| Operating Margin | 2.3% | 24.1% |
| Net Margin | — | 25.0% |
| Revenue YoY | 3.6% | 23.3% |
| Net Profit YoY | — | 17.3% |
| EPS (diluted) | $0.22 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $151.1M | $92.9M | ||
| Q3 25 | $126.8M | $67.5M | ||
| Q2 25 | $132.5M | $63.2M | ||
| Q1 25 | $135.7M | $52.6M | ||
| Q4 24 | $145.8M | $75.4M | ||
| Q3 24 | $122.3M | $57.9M | ||
| Q2 24 | $130.8M | $52.7M | ||
| Q1 24 | $136.8M | $51.3M |
| Q4 25 | — | $23.2M | ||
| Q3 25 | $1.6M | $5.1M | ||
| Q2 25 | $-17.2M | $-553.0K | ||
| Q1 25 | $7.8M | $-11.2M | ||
| Q4 24 | — | $19.8M | ||
| Q3 24 | $4.7M | $-901.0K | ||
| Q2 24 | $8.3M | $-4.7M | ||
| Q1 24 | $7.1M | $-3.9M |
| Q4 25 | 17.8% | 78.7% | ||
| Q3 25 | 15.1% | 73.5% | ||
| Q2 25 | 3.9% | 73.7% | ||
| Q1 25 | 22.0% | 69.0% | ||
| Q4 24 | 22.8% | 77.6% | ||
| Q3 24 | 18.5% | 71.9% | ||
| Q2 24 | 22.3% | 69.5% | ||
| Q1 24 | 21.5% | 68.9% |
| Q4 25 | 2.3% | 24.1% | ||
| Q3 25 | -2.7% | 5.1% | ||
| Q2 25 | -15.6% | -3.2% | ||
| Q1 25 | 6.2% | -24.3% | ||
| Q4 24 | 7.8% | 24.5% | ||
| Q3 24 | 3.1% | -4.3% | ||
| Q2 24 | 6.9% | -11.5% | ||
| Q1 24 | 5.5% | -10.7% |
| Q4 25 | — | 25.0% | ||
| Q3 25 | 1.2% | 7.5% | ||
| Q2 25 | -13.0% | -0.9% | ||
| Q1 25 | 5.7% | -21.4% | ||
| Q4 24 | — | 26.3% | ||
| Q3 24 | 3.9% | -1.6% | ||
| Q2 24 | 6.3% | -8.9% | ||
| Q1 24 | 5.2% | -7.5% |
| Q4 25 | $0.22 | $0.46 | ||
| Q3 25 | $0.10 | $0.10 | ||
| Q2 25 | $-1.05 | $-0.01 | ||
| Q1 25 | $0.46 | $-0.23 | ||
| Q4 24 | $0.62 | $0.40 | ||
| Q3 24 | $0.28 | $-0.02 | ||
| Q2 24 | $0.47 | $-0.10 | ||
| Q1 24 | $0.40 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $92.5M | $137.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $283.8M | $354.6M |
| Total Assets | $342.0M | $488.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $92.5M | $137.5M | ||
| Q3 25 | $80.8M | $135.4M | ||
| Q2 25 | $101.4M | $116.9M | ||
| Q1 25 | $108.3M | $112.9M | ||
| Q4 24 | $105.5M | $116.2M | ||
| Q3 24 | $96.0M | $101.7M | ||
| Q2 24 | $105.6M | $102.5M | ||
| Q1 24 | $115.3M | $110.6M |
| Q4 25 | $283.8M | $354.6M | ||
| Q3 25 | $279.6M | $321.9M | ||
| Q2 25 | $289.3M | $306.8M | ||
| Q1 25 | $321.5M | $295.5M | ||
| Q4 24 | $319.6M | $292.0M | ||
| Q3 24 | $314.9M | $257.5M | ||
| Q2 24 | $321.5M | $243.0M | ||
| Q1 24 | $332.0M | $233.9M |
| Q4 25 | $342.0M | $488.0M | ||
| Q3 25 | $342.3M | $453.3M | ||
| Q2 25 | $349.5M | $435.6M | ||
| Q1 25 | $379.0M | $424.6M | ||
| Q4 24 | $384.0M | $432.7M | ||
| Q3 24 | $373.5M | $390.4M | ||
| Q2 24 | $376.7M | $376.8M | ||
| Q1 24 | $385.0M | $356.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.5M | $15.0M |
| Free Cash FlowOCF − Capex | $12.3M | $12.8M |
| FCF MarginFCF / Revenue | 8.2% | 13.8% |
| Capex IntensityCapex / Revenue | 2.1% | 2.4% |
| Cash ConversionOCF / Net Profit | — | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | $38.5M | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.5M | $15.0M | ||
| Q3 25 | $12.9M | $22.1M | ||
| Q2 25 | $14.7M | $8.2M | ||
| Q1 25 | $11.1M | $6.6M | ||
| Q4 24 | $20.0M | $22.2M | ||
| Q3 24 | $9.4M | $10.2M | ||
| Q2 24 | $18.7M | $18.5M | ||
| Q1 24 | $7.3M | $7.2M |
| Q4 25 | $12.3M | $12.8M | ||
| Q3 25 | $7.0M | $19.5M | ||
| Q2 25 | $9.1M | $81.0K | ||
| Q1 25 | $10.0M | $-7.6M | ||
| Q4 24 | $16.4M | $8.5M | ||
| Q3 24 | $2.6M | $-9.2M | ||
| Q2 24 | $10.1M | $1.8M | ||
| Q1 24 | $5.6M | $-6.8M |
| Q4 25 | 8.2% | 13.8% | ||
| Q3 25 | 5.5% | 28.8% | ||
| Q2 25 | 6.9% | 0.1% | ||
| Q1 25 | 7.4% | -14.5% | ||
| Q4 24 | 11.2% | 11.2% | ||
| Q3 24 | 2.1% | -15.9% | ||
| Q2 24 | 7.7% | 3.4% | ||
| Q1 24 | 4.1% | -13.3% |
| Q4 25 | 2.1% | 2.4% | ||
| Q3 25 | 4.6% | 3.9% | ||
| Q2 25 | 4.2% | 12.9% | ||
| Q1 25 | 0.8% | 27.0% | ||
| Q4 24 | 2.5% | 18.3% | ||
| Q3 24 | 5.5% | 33.5% | ||
| Q2 24 | 6.6% | 31.8% | ||
| Q1 24 | 1.3% | 27.3% |
| Q4 25 | — | 0.65× | ||
| Q3 25 | 8.15× | 4.35× | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.43× | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | 1.98× | — | ||
| Q2 24 | 2.27× | — | ||
| Q1 24 | 1.04× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
